Marijuana could fight disease in future generations, as a recent study indicates that cannabis compounds have proven to have significant strength in the modification of gene activity.
Researchers from the University of South Carolina School of Medicine say they have discovered a particular group of microRNA that signifies a metamorphosis in rats exposed to tetrahydrocannabinol (THC).
This finding is significantly important became microRNA is a contributing factor in the regulation of genes, and many believe it is responsible for causing a variety of debilitating diseases.
According to lead researchers Prakash Nagarkatti, Ph.D. and Mitzi Nagarkatti, Ph.D., after studying nearly 610 various microRNAs, they found that 13 of them had a substantial reaction to THC, including “mir-690,” which had the most optimistic response and could eventually lead to advanced treatments for “inflammatory diseases as well as cancer.”
“While our study identifies the molecular mechanism of immune-altering effects of marijuana, select microRNA identified here could serve as important molecular targets to manipulate MDSC activity in cancer and inflammatory diseases,” said Dr. Mitzi Nagarkatti.
Interestingly, recent studies from Italian researchers have also led to the discovery of evidence that suggests cannabinoids, specifically cannabidiol (CBD), cannabigerol (CBG) and cannabidivarin (CBV), could alter negative gene activity associated with cancerous skin disorders.
Italian researchers concluded that the scope of marijuana’s gene-modifying potential greatly surpassed skin disorders and could change the genetic reverberation of diseases like multiple sclerosis and other types of cancer.
Mike Adams writes for Playboy's The Smoking Jacket, BroBible and Hustler Magazine. Follow him: @adamssoup; facebook.com/mikeadams73.